{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:40:06Z","timestamp":1792712406829,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.labinv.2026.106160","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:52:59Z","timestamp":1787673179000},"page":"106160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial Transcriptomics of Micropapillary, Plasmacytoid, and Sarcomatoid Urothelial Carcinoma Reveals Distinct Molecular Landscapes"],"prefix":"10.1016","volume":"106","author":[{"given":"Ting","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Nawrocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda T.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Blute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-0068","authenticated-orcid":false,"given":"Chin-Lee","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.labinv.2026.106160_bib1","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.labinv.2026.106160_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00345-025-05540-5","article-title":"A histopathological snapshot of bladder cancer: a Johannesburg experience of 1480 histopathology reports","volume":"43","author":"Jonosky","year":"2025","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.labinv.2026.106160_bib3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00345-020-03364-z","article-title":"The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre","volume":"39","author":"Naspro","year":"2021","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.labinv.2026.106160_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bju.15984","article-title":"Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy","volume":"132","author":"Claps","year":"2023","journal-title":"BJU Int"},{"issue":"7492","key":"10.1016\/j.labinv.2026.106160_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.labinv.2026.106160_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"Bladder Cancer Molecular Taxonomy Group. A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"issue":"7871","key":"10.1016\/j.labinv.2026.106160_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.labinv.2026.106160_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s42003-024-06426-9","article-title":"Digital spatial profiling of the microenvironment of muscle invasive bladder cancer","volume":"7","author":"Eyers","year":"2024","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.labinv.2026.106160_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70021","article-title":"Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells","volume":"11","author":"Johnson","year":"2025","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.labinv.2026.106160_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.890410","article-title":"Challenges and opportunities for immunoprofiling using a spatial high-plex technology: the NanoString GeoMx\u00ae Digital Spatial Profiler","volume":"12","author":"Hernandez","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.labinv.2026.106160_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.labinv.2026.106160_bib12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.labinv.2026.106160_bib13","author":"Lenth"},{"issue":"6","key":"10.1016\/j.labinv.2026.106160_bib14","article-title":"Thirteen years of clusterProfiler","volume":"5","author":"Yu","year":"2024","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.labinv.2026.106160_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","article-title":"Meta-analysis of the luminal and basal subtypes of bladder cancer and the identification of signature immunohistochemical markers for clinical use","volume":"12","author":"Dadhania","year":"2016","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.labinv.2026.106160_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.labinv.2026.106160_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.eururo.2016.02.056","article-title":"Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer","volume":"70","author":"Guo","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.labinv.2026.106160_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2018.05.022","article-title":"Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype","volume":"80","author":"Zinnall","year":"2018","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.labinv.2026.106160_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.urolonc.2019.09.025","article-title":"Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer","volume":"37","author":"Genitsch","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.labinv.2026.106160_bib20","article-title":"Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications","volume":"37","author":"Weiss","year":"2023","journal-title":"Cancer Treat Res Commun"},{"issue":"7","key":"10.1016\/j.labinv.2026.106160_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","article-title":"Molecular profile of bladder cancer progression to clinically aggressive subtypes","volume":"21","author":"Guo","year":"2024","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1016\/j.labinv.2026.106160_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41585-025-01075-x","article-title":"HER2 and urothelial carcinoma: current understanding and future directions","volume":"23","author":"Raggi","year":"2026","journal-title":"Nat Rev Urol"},{"issue":"8","key":"10.1016\/j.labinv.2026.106160_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PAI.0000000000000938","article-title":"Expression of nectin-4 in bladder urothelial carcinoma, in morphologic variants, and nonurothelial histotypes","volume":"29","author":"Hoffman-Censits","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106160_bib24","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1038\/s41598-022-12528-3","article-title":"Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine","volume":"12","author":"Tsukahara","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.labinv.2026.106160_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12894-024-01534-4","article-title":"m6A reader IGF2BP2 promotes M2 macrophage polarization and malignant biological behavior of bladder cancer by stabilizing NRP1 mRNA expression","volume":"24","author":"Fu","year":"2024","journal-title":"BMC Urol"},{"key":"10.1016\/j.labinv.2026.106160_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7510120","article-title":"Identification of prognostic immune genes in bladder urothelial carcinoma","volume":"2020","author":"Su","year":"2020","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.labinv.2026.106160_bib27","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/modpathol.3800166","article-title":"Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein","volume":"17","author":"Nassar","year":"2004","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.labinv.2026.106160_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/cancers16040746","article-title":"Roles of androgen receptor signaling in urothelial carcinoma","volume":"16","author":"Sundi","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.labinv.2026.106160_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/ERC-11-0010","article-title":"Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells","volume":"18","author":"Zheng","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"18","key":"10.1016\/j.labinv.2026.106160_bib30","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1074\/jbc.RA118.001689","article-title":"Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p","volume":"293","author":"Huang","year":"2018","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.labinv.2026.106160_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ijc.25700","article-title":"The plasmacytoid carcinoma of the bladder\u2014rare variant of aggressive urothelial carcinoma","volume":"129","author":"Keck","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.labinv.2026.106160_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.685980","article-title":"Role of NRP1 in bladder cancer pathogenesis and progression","volume":"11","author":"Dong","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2026.106160_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-022-01291-7","article-title":"Integrated proteogenomic characterization of urothelial carcinoma of the bladder","volume":"15","author":"Xu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10.1016\/j.labinv.2026.106160_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31083\/j.fbl2909327","article-title":"Cathepsin C promotes tumorigenesis in bladder cancer by activating the Wnt\/\u03b2-catenin signalling pathway","volume":"29","author":"Wang","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"10.1016\/j.labinv.2026.106160_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/BLC-150023","article-title":"Id proteins contribute to tumor development and metastatic colonization in a model of bladder carcinogenesis","volume":"1","author":"Garcia-Cao","year":"2015","journal-title":"Bladder Cancer"},{"issue":"11","key":"10.1016\/j.labinv.2026.106160_bib36","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.3390\/cancers15112924","article-title":"LEM domain containing 1 acts as a novel oncogene and therapeutic target for triple-negative breast cancer","volume":"15","author":"Li","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.labinv.2026.106160_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.594705","article-title":"Upregulation of fatty acid transporters is associated with tumor progression in non-muscle-invasive bladder cancer","volume":"27","author":"Jeong","year":"2021","journal-title":"Pathol Oncol Res"},{"issue":"10","key":"10.1016\/j.labinv.2026.106160_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/14737140.2020.1813029","article-title":"Gender discrepancies in bladder cancer: potential explanations","volume":"20","author":"Viswambaram","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"issue":"7","key":"10.1016\/j.labinv.2026.106160_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ece3.9062","article-title":"Fixed or random? On the reliability of mixed-effects models for a small number of levels in grouping variables","volume":"12","author":"Oberpriller","year":"2022","journal-title":"Ecol Evol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:06:31Z","timestamp":1792710391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683726000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0023683726000905"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106160","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial Transcriptomics of Micropapillary, Plasmacytoid, and Sarcomatoid Urothelial Carcinoma Reveals Distinct Molecular Landscapes","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106160"}}